• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Embla Medical

28.30 DKK+0.35 %28.7, 17.10
Less than 1K followers

EMBLA

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+0.35 %
+7.20 %
+2.35 %
-10.44 %
-12.92 %
-12.11 %
-13.46 %
-39.85 %
+414.55 %

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Read more
Market cap
12.11B DKK
Turnover
1.65M DKK
Revenue
5.91B
EBIT %
13.49 %
P/E
22.71
Dividend yield-%
-
Coverage
Disclaimer
Michael Friis
Michael Friis

Head of Equities

Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20.10
2026

Interim report Q3'26

2.2
2027

Annual report '26

Regulatory press release28.07.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Dagens aktienyheder 22/07/2026: Embla Medical
Analyst Comment22.07.2026, 08.40 by
Victor Skriver

Dagens aktienyheder 22/07/2026: Embla Medical

Dagens aktienyheder 22/07/2026: Embla Medical

Embla Medical
Embla Medical: Recording of Q2 2026 results presentation
Analyst Comment21.07.2026, 12.16 by
Victor Skriver

Embla Medical: Recording of Q2 2026 results presentation

Today, Embla Medical's CEO, Sveinn Sölvason, presented the Q2 2026 results and outlined the key drivers behind them, as well as the adjusted 2026 guidance. Focus was also directed towards advancements in innovation and how these are driving growth. You can watch a recording of the presentation here.

Embla Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Embla Medical – Presentation of the H1 2026 Interim Report
Webcast21.07.2026, 10.30

Embla Medical – Presentation of the H1 2026 Interim Report

Embla Medical will publish its interim report for H1 2026 on 21 July 2026. At 10:30 CET, CEO Sveinn Sölvason will present the results, comment on the most important developments in the business, and provide an update on the company's outlook for the remainder of 2026, followed by a live online Q&A session.

Embla Medical
Dagens aktienyheder 21/07/2026: Embla Medical, Lundbeck og GrønlandsBANKEN
Analyst Comment21.07.2026, 08.47 by
Victor Skriver

Dagens aktienyheder 21/07/2026: Embla Medical, Lundbeck og GrønlandsBANKEN

Dagens aktienyheder 21/07/2026: Embla Medical, Lundbeck og GrønlandsBANKEN

Embla MedicalLundbeckGrønlandsbanken
Mød ledelsen i Embla Medical og stil spørgsmål til dagens investorpræsentation
Analyst Comment21.07.2026, 08.30 by
Victor Skriver

Mød ledelsen i Embla Medical og stil spørgsmål til dagens investorpræsentation

Her til formiddag kl. 10:30 vil Embla Medical CEO Sveinn Sölvason præsentere halvårsrapporten for H1 2026, kommentere på de vigtigste forretningsmæssige tendenser og give en opdatering på forventningerne til resten af 2026, efterfulgt af en Q&A-session med publikum. Tilmeld dig og stil dine spørgsmål allerede nu.

Embla Medical
Regulatory press release21.07.2026, 07.00

Embla Medical hf: Interim Report Q2 2026

Embla Medical
Regulatory press release17.07.2026, 15.30

Embla Medical hf: Initiating New Share Buyback Program

Embla Medical
Regulatory press release17.07.2026, 15.00

Embla Medical hf: Share Buyback Program Completed

Embla Medical
Regulatory press release13.07.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Press release07.07.2026, 08.00

Embla Medical hf: Conference call details for Q2 2026

Embla Medical
Regulatory press release06.07.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release29.06.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release22.06.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release15.06.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release08.06.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release01.06.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release26.05.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release18.05.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release11.05.2026, 17.00

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical